Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
2.600
-0.190 (-6.81%)
Apr 1, 2025, 10:41 AM EDT - Market open
Venus Concept Market Cap
Venus Concept has a market cap or net worth of $1.71 million as of April 1, 2025. Its market cap has decreased by -57.13% in one year.
Market Cap
1.71M
Enterprise Value
40.60M
1-Year Change
-57.13%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since October 12, 2017, Venus Concept's market cap has decreased from $278.20M to $1.71M, a decrease of -99.38%. That is a compound annual growth rate of -49.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 2.00M | -25.93% |
| Dec 31, 2024 | 2.70M | -58.46% |
| Dec 29, 2023 | 6.50M | -69.91% |
| Dec 30, 2022 | 21.60M | -76.55% |
| Dec 31, 2021 | 92.10M | 29.35% |
| Dec 31, 2020 | 71.20M | -48.92% |
| Dec 31, 2019 | 139.40M | 687.57% |
| Dec 31, 2018 | 17.70M | -86.70% |
| Dec 29, 2017 | 133.10M | -52.16% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |